期刊文献+

纤维连接蛋白作为室间隔缺损血清标志物的研究 被引量:3

Study on fibronectin as a serum biomarker of ventricular septal defect
原文传递
导出
摘要 目的:验证纤维连接蛋白是否可以作为室间隔缺损(VSD)患者血清标志物。方法:收集室间隔缺损患者血清和与之年龄、性别、民族匹配的房间隔缺损患者、法洛氏四联症患者和健康对照者血清各20例,应用免疫印迹法(Westernblot)和酶联免疫吸附试验(enzyme linked immunosorbent assay,ELISA)检测血清样本中纤维连接蛋白表达水平。结果:免疫印迹法检测结果显示,纤维连接蛋白在VSD组、ASD组、TOF组和健康体检者血清中均能检测到,但在VSD组中的表达水平明显高于其他3组(P<0.05);ELISA检测显示VSD组患者血清中纤维连接蛋白浓度为(67.08±27.67)μg/L,ASD组患者为(37.65±15.07)μg/L、TOF组患者为(28.08±11.24)μg/L、健康体检者为(31.15±11.18)μg/L,4组间差异有统计学意义(P<0.05);进一步进行两两比较,VSD组与其他3组差异均有统计学意义(P<0.05),而其他3组差异均无统计学意义(P>0.05)。结论:纤维连接蛋白在VSD患者血清中的含量较高,有可能作为VSD的血清标志物,但有待于进一步的临床大样本验证。 Objective: To validate whether fibronectin can be used as a serum molecular marker of patients with ventricular septal defect (VSD) . Methods : The serum samples were obtained from 20 children with VSD, 20 children with atrial septal defect ( ASD), 20 children with tetralogy of Fallot (TOF), and 20 healthy children, who were well matched in age, gender, and race, respectively. Fibronec- tin expression level in serum samples was detected by Western blot and ELISA. Res^dts: Western blot analysis showed that fibronectin was detected in all serum samples of children with VSD, ASD, TOF and healthy children. However, fibronectin expression level in VSD group was significantly higher than that in the other three groups (P 〈 0.05) . The results of ELISA indicated that the serum concentrations of fi- bronectin in VSD group, ASD group, TOF group, and healthy children were (67. 08±27. 67) μg/L, (37. 65 ± 15.07) μg/L, (28.08 ± 11. 24) μg/L, and (31.15 ± 11. 18) μg/L, respectively; there was statistically significant difference among the four groups (P 〈0. 05) ; the results of further comparison between every two groups, there was statistically significant difference between VSD group and the other three groups respectively (P 〈 0. 05), and there was no statistically significant difference among the other three groups ( P 〉 0. 05) . Con- clusion: Fibronectin expression level is higher in serum of patients with VSD, which can be used as a serum biomarker for VSD, but it needs to be further validated in large clinical samples study.
出处 《中国妇幼保健》 CAS 北大核心 2013年第1期163-166,共4页 Maternal and Child Health Care of China
基金 广西自然科学基金重点项目〔2010GXNSFD013054〕
关键词 室间隔缺损 纤维连接蛋白 血清标志物 Ventricular septal defect Fibronectin Serum biomarker
  • 相关文献

参考文献14

  • 1余章斌,韩树萍,朱春,董小玥,郭锡熔.基因表达谱芯片筛选室间隔缺损胎儿心肌组织差异表达基因[J].实用儿科临床杂志,2011,26(18):1425-1428. 被引量:7
  • 2Penny DJ, Vick GW 3rd. Ventricular septal defect [J]. Lancet, 2011, 377 (9771)) : 1103.
  • 3张永波,仇小强,曾小云,何敏,周怡,罗荣,李洪涛,余红平.基于iTRAQ技术筛选室间隔缺损患儿血清蛋白标志物[J].中国妇幼保健,2012,27(12):1862-1866. 被引量:3
  • 4Yu H, Smallwood PM, Wang Y et al. Frizzled 1 and frizzled 2 genes function in palate, ventricular septum and neural tube closure: general implications for tissue fusion processes [J]. Development, 2010, 137 (21) : 3707.
  • 5Thadikkaran L, Siegenthaler MA, Crettaz D et al. Recent advances in blood - related proteomics [J]. Proteomics, 2005, 5 (12): 3019.
  • 6Rehman I, Evans CA, Glen A et al. iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer [J]. PLoS One, 2012, 7 (2) : e30885.
  • 7Loci H, Tan HT, Lira TK et al. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer [J].J Proteome Res, 2012, 11 (3) : 1759.
  • 8Danen EH, Yamada KM. Fn, integrins and growth control [J]. J Cell Physiol, 2001, 189:1.
  • 9Lockhart M, Wirrig E, Phelps A et al. Extracellular matrix and heart development[J]. Birth Defects Res A Clin Mol Teratol, 2011,91 (6) :535.
  • 10Garita B, Jenkins MW, Han Met al. Blood flow dynamics of one cardiac cycle and relationship to mechanotransduction and trabeculation during heart looping [J]. Am J Physiol Heart Circ Physiol, 2011, 300 (3) : H879.

二级参考文献18

  • 1Pierpont ME,Basson CT,Benson DW Jr et al.Genetic basis for congenital heart defects:current knowledge:a scientific statement from the American Heart Association Congenital Car-diac Defects Committee,Council on cardiovascular disease in the young[J].Circulation,2007,115(23):3015.
  • 2Tayade C,Esadeg S,Fang Y et al.Functions of alpha 2 mac-roglobulins in pregnancy[J].Mol Cell Endocrinol,2005,245(1-2):60.
  • 3Zhou HM,Weskamp G,Chesneau V et al.Essential role for ADAM19 in cardiovascular morphogenesis[J].Mol Cell Bi-ol,2004,24(1):96.
  • 4Kern CB,Twal WO,Mjaatvedt CH et al.Proteolytic cleavage of versican during cardiac cushion morphogenesis[J].Dev Dyn,2006,235(8):2238.
  • 5Ijsselstijn L,Dekker LJ,Stingl C et al.Serum levels of preg-nancy zone protein are elevated in presymptomatic Alzheimer'sdisease[J].J Proteome Res,2011,10(11):4902.
  • 6Leipner C,Grün K,Müller A et al.Imatinib mesylate attenu-ates fibrosis in coxsackievirus b3-induced chronic myocarditis[J].Cardiovasc Res,2008,79(1):118.
  • 7Watanabe T,Koibuchi N,Chin MT.Transcription factor CHF1/Hey2 regulates coronary vascular maturation[J].Mech Dev,2010,127(9-12):418.
  • 8Richarte AM,Mead HB,Tallquist MD.Cooperation between the PDGF receptors in cardiac neural crest cell migration[J].Dev Biol,2007,306(2):785.
  • 9Lockhart M,Wirrig E,Phelps A et al.Extracellular matrix and heart development[J].Birth Defects Res A Clin Mol Tera-tol,2011,91(6):535.
  • 10黄国英.心脏神经嵴细胞与先天性心脏病的发生机制[J].实用儿科临床杂志,2009,24(1):1-3. 被引量:4

共引文献12

同被引文献25

  • 1吴红霞,李永青,吴秀山.脊椎动物心脏形态发育的转录调控[J].生命科学研究,2002,6(S2):101-105. 被引量:57
  • 2钟秋安,仇小强,曾小云,林娜娜.儿童不分型先天性心脏病及室间隔缺损致病因素的比较分析[J].中国妇幼保健,2007,22(18):2497-2500. 被引量:8
  • 3Stoll C, Dott B, Alembik Y, et al. Evaluation and evolutionduring time of prenatal diagnosis of congenital heart diseases by routine fetal ultrasonographic examination [ J] . Ann Genet, 2002, 45 (3): 115-121.
  • 4Robinson JN, Simpson LL, Abuhamad AZ. Screening for fetal heart disease with ultrasound [ J] . Clin Obstet Gynecol, 2003, 46 (4): 890-896.
  • 5Bahtiyar MO, Dulay AT, Weeks BP, et al. Prenatal course of isolated muscular ventricular septal defects diagnosed only by color Doppler sonography: single - institution experience [ J] . J Ultrasound Med, 2008, 27 (5) : 715 -720.
  • 6Hijazi ZM, Hakim F, Haweleh AA, et al. Catheter closure of perimembranous ventricular septal defects using the new Amp- latzer membranous VSD occluder: initial clinical experience [ J] . Catheter Cardiovasc Interv, 2002, 56 (4) : 508 - 515.
  • 7Espinoza J, Kalache K, Goncalves LF, et al. Prenatal diag- nosis of membranous ventricular septal aneurysms and their association with absence of atrioventrieular valve "offsetting" [J] Ultrasound Obstet Gyneeol, 2004, 24 (7) : 787 - 792.
  • 8Miyake T, Shinohara T, Nakamura Y, et al. Aneurysm of the ventricular membranous septum: serial eehocardiographic studies [J] . Pediatr Cardiol, 2004, 25 (4): 385-389.
  • 9Jin Y, Wang A, Wang Y, et al. Natural history of prenatal ventricular septal defects and their association with fetal echo- cardiographie features [ J] . Cardiol Young, 2012, 22 ( 3 ) : 323 - 326.
  • 10T. Sayer,J. Lim,J. M. Gauld,P. Hinoul,P. Jones,N. Franco,D. Drie,M. Slack.Medium-term clinical outcomes following surgical repair for vaginal prolapse with tension-free mesh and vaginal support device[J].International Urogynecology Journal.2012(4)

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部